- Home
- RF vs ILMN Comparison
RF vs ILMN Comparison
Compare RF & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RF
- ILMN
- Stock Information
- Founded
- RF 1970
- ILMN 1998
- Country
- RF United States
- ILMN United States
- Employees
- RF N/A
- ILMN N/A
- Industry
- RF Major Banks
- ILMN Medical Specialities
- Sector
- RF Finance
- ILMN Health Care
- Exchange
- RF Nasdaq
- ILMN Nasdaq
- Market Cap
- RF 23.8B
- ILMN 22.9B
- IPO Year
- RF N/A
- ILMN 2000
- Fundamental
- Price
- RF $26.54
- ILMN $145.15
- Analyst Decision
- RF Buy
- ILMN Buy
- Analyst Count
- RF 17
- ILMN 20
- Target Price
- RF $26.41
- ILMN $160.68
- AVG Volume (30 Days)
- RF 7.6M
- ILMN 2.4M
- Earning Date
- RF 01-17-2025
- ILMN 11-04-2024
- Dividend Yield
- RF 3.75%
- ILMN N/A
- EPS Growth
- RF N/A
- ILMN N/A
- EPS
- RF 1.77
- ILMN N/A
- Revenue
- RF $6,556,000,000.00
- ILMN $4,390,000,000.00
- Revenue This Year
- RF N/A
- ILMN N/A
- Revenue Next Year
- RF $5.33
- ILMN $4.28
- P/E Ratio
- RF $14.98
- ILMN N/A
- Revenue Growth
- RF N/A
- ILMN N/A
- 52 Week Low
- RF $16.86
- ILMN $97.36
- 52 Week High
- RF $27.96
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- RF 59.43
- ILMN 53.75
- Support Level
- RF $25.98
- ILMN $140.56
- Resistance Level
- RF $27.63
- ILMN $146.30
- Average True Range (ATR)
- RF 0.45
- ILMN 4.78
- MACD
- RF -0.03
- ILMN 0.27
- Stochastic Oscillator
- RF 30.05
- ILMN 70.95
About RF Regions Financial Corporation
Regions Financial is a regional bank headquartered in Alabama, with branches primarily in the Southeastern and Midwestern United States. Regions primarily provides traditional commercial and retail banking and also offers mortgage services, asset management, wealth management, securities brokerage, and trust services.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.